Aramark — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Aramark filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 29, 2017 | $3.65B | Nov 22, 2017 |
| FY2017 | Jun 30, 2017 | $3.59B | Nov 22, 2017 |
| FY2017 | Mar 31, 2017 | $3.62B | Nov 22, 2017 |
| FY2017 | Dec 30, 2016 | $3.74B | Nov 22, 2017 |
| FY2017 | Sep 30, 2016 | $3.54B | Nov 22, 2017 |
| FY2017 | Jul 1, 2016 | $3.59B | Nov 22, 2017 |
| FY2017 | Apr 1, 2016 | $3.57B | Nov 22, 2017 |
| FY2017 | Jan 1, 2016 | $3.71B | Nov 22, 2017 |
| FY2016 | Oct 2, 2015 | $3.55B | Nov 23, 2016 |
| FY2016 | Jul 3, 2015 | $3.49B | Nov 23, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $326.39M | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $262.52M | Nov 25, 2025 |
| FY2025 | Sep 29, 2023 | $674.11M | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $194.48M | Nov 19, 2024 |
| FY2023 | Oct 1, 2021 | ($90.83M) | Nov 21, 2023 |
| FY2020 | Oct 2, 2020 | ($148.59M) | Nov 24, 2020 |
| FY2020 | Jun 26, 2020 | ($256.44M) | Nov 24, 2020 |
| FY2020 | Mar 27, 2020 | ($202.26M) | Nov 24, 2020 |
| FY2020 | Dec 27, 2019 | $145.76M | Nov 24, 2020 |
| FY2020 | Sep 27, 2019 | $85.56M | Nov 24, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $791.85M | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $706.51M | Nov 25, 2025 |
| FY2025 | Sep 29, 2023 | $625.03M | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $415.39M | Nov 19, 2024 |
| FY2023 | Oct 1, 2021 | $191.44M | Nov 21, 2023 |
| FY2022 | Oct 2, 2020 | ($264.92M) | Nov 22, 2022 |
| FY2021 | Sep 27, 2019 | $891.16M | Nov 23, 2021 |
| FY2020 | Sep 28, 2018 | $818.41M | Nov 24, 2020 |
| FY2019 | Sep 29, 2017 | $801.63M | Nov 26, 2019 |
| FY2018 | Sep 30, 2016 | $746.31M | Nov 21, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $278.44M | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $283.63M | Nov 25, 2025 |
| FY2025 | Sep 29, 2023 | $273.66M | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $258.36M | Nov 19, 2024 |
| FY2023 | Oct 1, 2021 | $346.75M | Nov 21, 2023 |
| FY2022 | Oct 2, 2020 | $307.02M | Nov 22, 2022 |
| FY2021 | Sep 27, 2019 | $367.26M | Nov 23, 2021 |
| FY2020 | Sep 28, 2018 | $377.13M | Nov 24, 2020 |
| FY2019 | Sep 29, 2017 | $299.17M | Nov 26, 2019 |
| FY2018 | Sep 30, 2016 | $283.34M | Nov 21, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Sep 29, 2023 | $766.43M | Nov 21, 2023 |
| FY2023 | Sep 30, 2022 | $694.50M | Nov 21, 2023 |
| FY2023 | Oct 1, 2021 | $657.08M | Nov 21, 2023 |
| FY2022 | Oct 2, 2020 | $176.68M | Nov 22, 2022 |
| FY2021 | Sep 27, 2019 | $984.23M | Nov 23, 2021 |
| FY2020 | Sep 28, 2018 | $1.05B | Nov 24, 2020 |
| FY2019 | Sep 29, 2017 | $1.05B | Nov 26, 2019 |
| FY2018 | Sep 30, 2016 | $867.31M | Nov 21, 2018 |
| FY2017 | Oct 2, 2015 | $802.19M | Nov 22, 2017 |
| FY2016 | Oct 3, 2014 | $398.16M | Nov 23, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $13.30B | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $12.67B | Nov 25, 2025 |
| FY2024 | Sep 29, 2023 | $16.87B | Nov 19, 2024 |
| FY2023 | Sep 30, 2022 | $15.08B | Nov 21, 2023 |
| FY2022 | Oct 1, 2021 | $14.38B | Nov 22, 2022 |
| FY2021 | Oct 2, 2020 | $15.71B | Nov 23, 2021 |
| FY2020 | Sep 27, 2019 | $13.74B | Nov 24, 2020 |
| FY2019 | Sep 28, 2018 | $13.72B | Nov 26, 2019 |
| FY2018 | Sep 29, 2017 | $11.01B | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $10.58B | Nov 22, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $3.15B | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $3.04B | Nov 25, 2025 |
| FY2025 | Sep 29, 2023 | $3.71B | Nov 25, 2025 |
| FY2025 | Sep 30, 2022 | $3.03B | Nov 25, 2025 |
| FY2024 | Oct 1, 2021 | $2.72B | Nov 19, 2024 |
| FY2023 | Oct 2, 2020 | $2.74B | Nov 21, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $4.87B | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $4.68B | Nov 25, 2025 |
| FY2024 | Sep 29, 2023 | $4.62B | Nov 19, 2024 |
| FY2023 | Sep 30, 2022 | $5.52B | Nov 21, 2023 |
| FY2022 | Oct 1, 2021 | $5.49B | Nov 22, 2022 |
| FY2021 | Oct 2, 2020 | $5.34B | Nov 23, 2021 |
| FY2020 | Sep 27, 2019 | $5.52B | Nov 24, 2020 |
| FY2019 | Sep 28, 2018 | $5.61B | Nov 26, 2019 |
| FY2018 | Sep 29, 2017 | $4.72B | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | $4.63B | Nov 22, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $453.28M | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $239.71M | Nov 25, 2025 |
| FY2024 | Sep 29, 2023 | $964.16M | Nov 19, 2024 |
| FY2023 | Sep 30, 2022 | $406.78M | Nov 21, 2023 |
| FY2022 | Oct 1, 2021 | $327.56M | Nov 22, 2022 |
| FY2021 | Oct 2, 2020 | $532.38M | Nov 23, 2021 |
| FY2020 | Sep 27, 2019 | $1.11B | Nov 24, 2020 |
| FY2019 | Sep 28, 2018 | $710.52M | Nov 26, 2019 |
| FY2018 | Sep 29, 2017 | $247.05M | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | ($33.78M) | Nov 22, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $639.10M | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $672.48M | Nov 25, 2025 |
| FY2025 | Sep 29, 2023 | $1.93B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $305.72M | Nov 19, 2024 |
| FY2022 | Oct 1, 2021 | $532.59M | Nov 22, 2022 |
| FY2021 | Oct 2, 2020 | $2.51B | Nov 23, 2021 |
| FY2020 | Sep 27, 2019 | $246.64M | Nov 24, 2020 |
| FY2019 | Sep 28, 2018 | $215.03M | Nov 26, 2019 |
| FY2019 | Sep 29, 2017 | $238.80M | Nov 26, 2019 |
| FY2019 | Sep 30, 2016 | $152.58M | Nov 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Sep 27, 2019 | $0 | Nov 24, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | 1 | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | 1 | Nov 25, 2025 |
| FY2025 | Sep 29, 2023 | 2 | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Nov 19, 2024 |
| FY2023 | Oct 1, 2021 | 0 | Nov 21, 2023 |
| FY2020 | Oct 2, 2020 | 0 | Nov 24, 2020 |
| FY2020 | Jun 26, 2020 | (1) | Nov 24, 2020 |
| FY2020 | Mar 27, 2020 | 0 | Nov 24, 2020 |
| FY2020 | Dec 27, 2019 | 0 | Nov 24, 2020 |
| FY2020 | Sep 27, 2019 | 0 | Nov 24, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | 1 | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | 0 | Nov 25, 2025 |
| FY2025 | Sep 29, 2023 | 2 | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | 0 | Nov 19, 2024 |
| FY2023 | Oct 1, 2021 | 0 | Nov 21, 2023 |
| FY2020 | Oct 2, 2020 | 0 | Nov 24, 2020 |
| FY2020 | Jun 26, 2020 | (1) | Nov 24, 2020 |
| FY2020 | Mar 27, 2020 | 0 | Nov 24, 2020 |
| FY2020 | Dec 27, 2019 | 0 | Nov 24, 2020 |
| FY2020 | Sep 27, 2019 | 0 | Nov 24, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | 262.90M | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | 263.94M | Nov 25, 2025 |
| FY2024 | Sep 29, 2023 | 261.45M | Nov 19, 2024 |
| FY2023 | Sep 30, 2022 | 258.73M | Nov 21, 2023 |
| FY2022 | Oct 1, 2021 | 256.00M | Nov 22, 2022 |
| FY2021 | Oct 2, 2020 | 253.04M | Nov 23, 2021 |
| FY2020 | Sep 27, 2019 | 247.76M | Nov 24, 2020 |
| FY2019 | Sep 28, 2018 | 246.74M | Nov 26, 2019 |
| FY2018 | Sep 29, 2017 | 245.59M | Nov 21, 2018 |
| FY2017 | Sep 30, 2016 | 244.71M | Nov 22, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 3, 2025 | $110.82M | Nov 25, 2025 |
| FY2025 | Sep 27, 2024 | $99.90M | Nov 25, 2025 |
| FY2025 | Sep 29, 2023 | $114.61M | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $113.12M | Nov 19, 2024 |
| FY2023 | Oct 1, 2021 | $112.01M | Nov 21, 2023 |
| FY2022 | Oct 2, 2020 | $110.89M | Nov 22, 2022 |
| FY2021 | Sep 27, 2019 | $108.44M | Nov 23, 2021 |
| FY2020 | Sep 28, 2018 | $103.12M | Nov 24, 2020 |
| FY2019 | Sep 29, 2017 | $100.81M | Nov 26, 2019 |
| FY2018 | Sep 30, 2016 | $92.07M | Nov 21, 2018 |